The von Hippel-Lindau (VHL) disease tumor-suppressor gene is not mutated in nasopharyngeal carcinomas

This publication has 10 references indexed in Scilit:

• Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: Correlations with phenotype
  Human Mutation, 1995
• Mutations of the VHL tumour suppressor gene in renal carcinoma
  Nature Genetics, 1994
• Etiology of Nasopharyngeal Carcinoma: A Review
  Epidemiologic Reviews, 1993
• Dosage‐dependent dominance over wild‐type p53 of a mutant p53 isolated from nasopharyngeal carcinoma ¹
  The FASEB Journal, 1993
• Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
  Science, 1993
• Progression toward tumor cell phenotype is enhanced by overexpression of a mutant p53 tumor-suppressor gene isolated from nasopharyngeal carcinoma.
  Proceedings of the National Academy of Sciences, 1993
• An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma.
  Proceedings of the National Academy of Sciences, 1992
• Loss of heterozygosity on the short arm of chromosome 3 in nasopharyngeal carcinoma
  Cancer Genetics and Cytogenetics, 1991
• Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas.
  Proceedings of the National Academy of Sciences, 1989
• Establishment and characterization of three transplantable EBV‐containing nasopharyngeal carcinomas
  International Journal of Cancer, 1988